Items where Author is "Warschkow, R."
Jump to: 2016 Number of items: 2. 2016Neumair, P. and Joos, L. and Warschkow, R. and Ess, S. and Hitz, F. and Frueh, M. and Brutsche, M. H. and Baty, F. and Krahenbuhl, S. and Jorger, M.. (2016) 169P: Chemotherapy is not superior to erlotinib in pretreated patients with advanced non-small cell lung cancer (NSCLC): A retrospective study. Journal of Thoracic Oncology, 11 (4 Suppl). p. 131. Neumair, P. and Joos, L. and Warschkow, R. and Dutly, A. and Ess, S. and Hitz, F. and Fruh, M. and Brutsche, M. and Baty, F. and Krahenbuhl, S. and Cerny, T. and Joerger, M.. (2016) Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study. Lung Cancer, 100. pp. 38-44. |
